Technical Data
A0855-90C
Activin Receptor Type IB (ALK-4, RIB)
Description:
Applications:
Suitable for use in Neutralization, ELISA and Western Blot. Other applications not tested.

Recommended Dilution:
Western Blot: 0.1-0.2ug/ml
Neutralization of receptor-ligand interaction: 0.5-1.0ug/ml Blocks < 95% of the binding of 50ng/mL of rhCripto 1 to immobilized rhActRIB/Fc 100ul of 2ug/ml was coated in each well) in a functional ELISA. 50% inhibition occurs at an antibody concentration of approximately
0.5-2ug/ml.
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
100ug-20CBlue IceHumanGoat
Concentration:
~0.1mg/ml (after reconstitution)
Immunogen:
NS0-derived recombinant protein corresponding to human Activin RIB extracellular domain.
Purity:
Purified by immunoaffinity chromatography.
Form
Supplied as a lyophilized powder in 0.2um sterile-filtered solution in PBS with 5% trehalose, pH 7.4. Reconstitute with sterile PBS.
Specificity:
Recognizes human Activin RIB.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.